Market revenue in 2023 | USD 1,366.5 million |
Market revenue in 2030 | USD 1,808.8 million |
Growth rate | 4.1% (CAGR from 2023 to 2030) |
Largest segment | Frozen nondonor |
Fastest growing segment | Frozen Nondonor |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Fresh Nondonor, Frozen Nondonor, Fresh Donor, Frozen Donor |
Key market players worldwide | Bayer AG, Cook Medical, Merck KGaA, Ferring, FUJIFILM Holdings Corp, Genea Biomedx, Merck & Co Inc, The Cooper Companies Inc, Thermo Fisher Scientific Inc, Vitrolife AB ADR, Boston Scientific Corp, Nova IVF, Fortis Healthcare, RMA Network, TFP Fertility Group, US Fertility |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to in vitro fertilization market will help companies and investors design strategic landscapes.
Frozen nondonor was the largest segment with a revenue share of 48.35% in 2023. Horizon Databook has segmented the France in vitro fertilization market based on fresh nondonor, frozen nondonor, fresh donor, frozen donor covering the revenue growth of each sub-segment from 2018 to 2030.
In France, a majority of fertility treatments involve the use of intra-partner gametes, and the use of donated gametes is very rare. The prevalence of infertility has been on the rise in France, contributing to the demand for IVF treatments. Various factors, such as lifestyle changes, environmental factors, and medical conditions, can impact fertility, leading more individuals and couples to seek fertility assistance.
According to a report presented in 2022 to the Ministry of Health, infertility is considered a significant public health issue in France, affecting one in four couples of childbearing age. Government initiatives in France are expected to stimulate and enhance the demand for fertility treatments, including IVF.
These initiatives aim to address the growing concern surrounding infertility as a public health issue and provide support for couples facing fertility challenges. For instance, in June 2021, the lower house of parliament in France officially passed a law granting single women and lesbian couples access to medically assisted reproduction.
Horizon Databook provides a detailed overview of country-level data and insights on the France in vitro fertilization market , including forecasts for subscribers. This country databook contains high-level insights into France in vitro fertilization market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account